Skip to main content
Caplight Logo









Teiko Bio

Teiko Bio

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://teiko-labs.com/

Last Round

Series A

Dec 20, 2021

Total Funding Raised

$23.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Teiko Bio is a biotechnology company that provides a precision immune monitoring platform and contract research organization services for clinical trials and diagnostics development.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Healthcare Analytics, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts, Hardware Sales

AI Layer

Application

Keywords

immune profilingmass cytometrycontract research organizationCROclinical trial supportimmuno-oncologycytometry servicesbiomarker discoveryimmunophenotypinghigh-dimensional cytometrypatient response predictionbioanalytical servicesAI-powered analyticsspectral flow cytometryCyTOFCLIA-validated panelsautoimmune diseaseblood preservation kit

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Teiko Bio Comparables

Compare Teiko Bio with similar companies based on industry and business-model similarity.

Teiko Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IMU Biosciences
85%
Sirona Dx
81%
CellCarta
73%

Teiko Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 20, 2021
Series AOct 5, 2021
SeedJul 5, 2021

Key People

Founding team and executive leadership

Ramji Srinivasan

Founder and CEO

Founding Team

Teiko Bio Investors

Notable investors and investment history

Teiko Bio investors
InvestorRounds
Global Founders CapitalSeries A
Alix VenturesSeries A
EPIC VenturesSeries A
Tau VenturesSeed
Altitude LabSeed
HOF CapitalSeries A
Civilization VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2026

    Monthly visitors grew 169% MoM, reaching 12.2K.

  • Nov 13, 2025

    Presented new data at the SITC 2025 conference.

Teiko Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Teiko Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Teiko Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range23
Year Founded2020
Last FundingDec 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?